Home › Funds › HANCOCK WHITNEY CORP › AMGN

HANCOCK WHITNEY CORP position in AMGN

AMGEN INC · Health Care

HANCOCK WHITNEY CORP reported holding 143,155 shares of AMGN (AMGEN INC) in its Q2 2026 13F filing — a position valued at US$51.8M, representing 0.86% of its reported portfolio and ranking #23 among its reported holdings. HANCOCK WHITNEY CORP has disclosed AMGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)143.16K sh
Reported value held$51.84M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How HANCOCK WHITNEY CORP's AMGN position evolved

HANCOCK WHITNEY CORP first disclosed a stake in AMGN in Q3 2023 at 39,712 shares (US$10.7M). The position peaked in Q2 2026 at 143,155 shares, worth US$51.8M. Across 12 filings, HANCOCK WHITNEY CORP increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 143,155 shares valued at US$51.8M — a reduction of -2,868 shares quarter over quarter.. Notable position changes include a 60% increase in Q1 2025 (shares fell 11% over the following quarter), a 132% increase in Q2 2025 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 39.71K $10.67M New
Q4 2023 38.40K $11.06M Reduce
Q1 2024 43.93K $12.49M Add
Q2 2024 44.45K $13.89M Add
Q3 2024 44.32K $14.28M Hold
Q4 2024 41.85K $10.91M Reduce
Q1 2025 66.80K $20.81M Add
Q2 2025 154.99K $43.27M Add
Q3 2025 153.21K $43.24M Reduce
Q4 2025 149.98K $49.09M Reduce
Q1 2026 146.02K $51.00M Reduce
Q2 2026 143.16K $51.84M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 32 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), STATE STREET CORP (US$10.75B), Capital World Investors (US$10.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has HANCOCK WHITNEY CORP held AMGN?

HANCOCK WHITNEY CORP has disclosed AMGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is HANCOCK WHITNEY CORP's current position in AMGN?

As of Q2 2026, HANCOCK WHITNEY CORP holds 143.16K shares of AMGN (AMGEN INC), valued at $51.84M, representing 0.86% of its reported portfolio and ranking #23.

Has HANCOCK WHITNEY CORP been buying or selling AMGN?

In the latest 13F filing (Q2 2026), HANCOCK WHITNEY CORP reduced its position in AMGN. The position peaked in Q2 2026 at 143.16K shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, STATE STREET CORP, Capital World Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.